Events List
Discover conferences, symposia and other events worldwide.
View monthly calendar
Submit your event
708 event(s) found
ICHO-25: International Conference on Hematology and Oncology
Science Cite is delighted to welcome you to the International Conference on Hematology and Oncology at Tianjin,China on 04th - 05th Dec 2025. It's our pleasure to have a platform with all the field's leading scientists, outstanding researchers, academic people, and industrialists from national and international locations. All attendees and the domain will benefit from the discussions at conferences, seminars, workshops, symposia, and other related events. In addition, we offer a platform for all academicians to display their research and ideas and explore speaking opportunities. In addition to being united by a common goal - to provide information exchange and advance the fields. This conference will help you all make new connections, gain recognition and receive feedback to help you grow personally and professionally. Our goal is to create a motivating atmosphere and to discuss solutions, future strategies, and trends. Therefore, we look forward to your participation which means gaining immense exposure and helping people.
04/12/2025 - 05/12/2025
In-person
Science Cite
Tianjin, China
The Ritz-Carlton
San Antonio Breast Cancer Symposium® (SABCS)
The San Antonio Breast Cancer Symposium® is designed to provide state-of-the-art information on the experimental biology, etiology, prevention, diagnosis, and therapy of breast cancer and premalignant breast disease to an international audience of academic and private physicians and researchers. The scientific program consists of formal lectures by experts in clinical, translational, and basic research; selected slide and poster presentations; forums; and case discussions. The official language of the symposium is English. Simultaneous translation is not provided.
05/12/2025 - 11/12/2025 Hybrid UT Health San Antonio, AACR San Antonio, TX, United States Henry B. Gonzalez Convention Center
67th ASH Annual Meeting & Exposition
With hundreds of sessions, thousands of abstracts, and countless ways to experience the best in hematology, the ASH annual meeting is the world's premier global hematology event.
06/12/2025 - 09/12/2025 In-person ASH Orlando, United States Orange County Convention Center
ELN Breakfast Meeting at ASH
Invitations will follow as soon as the venue in Orlando has been confirmed.
07/12/2025 - 07/12/2025 In-person European LeukemiaNet (ELN) Orlando, United States Orange County Convention Center ICCGWO-25: International Conference on Clinical Gynecology and Women Oncology
International Conference on Clinical Gynecology and Women Oncology(ICCGWO-25) will be held in Shanghai, China on 9th - 10th December 2025 It is the hope of the ( ICCGWO-25) Conference that you will join us, either in person or online, to take complete advantage of all that this event has to offer. This entire conference has been organized with the sole intention of allowing participants access to the latest research insights, and opportunities to disseminate research, network with fellow professionals, and take advantage of opportunities to accelerate their careers. Atlantic Federation for Technical Education & Research (AFTER) is proud to host this event, which serves as a leading international stage for showcasing the latest advancements and innovations in the field. Our aim is to provide a dynamic platform where industry professionals and academics can come together to exchange ideas and discuss the latest developments. The focal point of this conference is to provide attendees with a chance to share their knowledge and insights with a worldwide audience. Our comprehensive program will include industry-driven presentations, expert panels, and keynote speeches from global thought leaders.
08/12/2025 - 09/12/2025 Hybrid AFTER Shanghai, China Swissotel Grand Shanghai AACR Special Conference in Cancer Research: The Rise in Early-Onset Cancers – Knowledge Gaps and Research Opportunities
AACR Special Conference in Cancer Research: The Rise in Early-Onset Cancers – Knowledge Gaps and Research Opportunities organized by AACR
10/12/2025 - 13/12/2025 In-person AACR Philadelphia, United States TBD AOFOG-ASGO Gynecologic Oncology Research Workshop
AOFOG-ASGO Gynecologic Oncology Research Workshop organized by AOFOG; ASGO
10/12/2025 - 13/12/2025 In-person AOFOG, ASGO Hong Kong, China TBD Flash Radiotherapy and Particle Therapy 2025 Conference
Flash Radiotherapy and Particle Therapy 2025 Conference organized by FRPT
10/12/2025 - 12/12/2025 In-person FRPT Prague, Czech Republic TBD ICTII 2025: 19th International Conference on Tumor Immunology and Immunotherapy
International Conference on Tumor Immunology and Immunotherapy aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Tumor Immunology and Immunotherapy. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Tumor Immunology and Immunotherapy.
10/12/2025 - 11/12/2025 Virtual WASET Macau, China TBD 33rd International TTD Symposium: Advances in the Treatment of Digestive Tumors
33rd International TTD Symposium: Advances in the Treatment of Digestive Tumors organized by TTD Group
10/12/2025 - 12/12/2025 In-person TTD Group Oviedo, Spain TBD 33rd International TTD Symposium: Advances in the Treatment of Digestive Tumors
33rd International TTD Symposium: Advances in the Treatment of Digestive Tumors organized by TTD Group
11/12/2025 - 12/12/2025 In-person TTD Group Oviedo, Spain TBD Best of ESMO India 2025
Best of ESMO India 2025 organized by ESMO; Global Healthcare Academy (GHA)
13/12/2025 - 14/12/2025 In-person ESMO, Global Healthcare Academy (GHA) Mumbai, India TBD
Detection of Minimal Residual Disease (MRD): A Highly Sensitive Tool for Monitoring Cancer Patients
We hope to see many of you at this event! Don't miss the next Ecosystem Breakfast on the topic: Detection of Minimal Residual Disease (MRD): A Highly Sensitive Tool for Monitoring Cancer Patients With: Charles Marcaillou, Head of R&D, IntegraGen Charles is a senior scientist and molecular biologist with over 25 years of expertise in genomics and a pioneer in next-generation sequencing technologies. As head of R&D, he has overseen the development, validation, and optimization of the full range of NGS-based applications offered by the company. Séverine Matin-Lannerée, PhD, Head of Quality, IntegraGen Séverine oversees regulatory compliance and quality management for high-throughput sequencing services, with a focus on applications in clinical research and trials, including liquid biopsy. She joined IntegraGen in 2017 after a career in academic and translational research on the molecular bases and mechanisms of cancer. She initially led R&D projects within the oncology biomarker team and acted as a scientific advisor. Céline Capéra, Head of Sales, IntegraGen Céline has led IntegraGen's Commercial team since 2021. Having joined the team in 2010, she has helped IntegraGen become a European leader in genomics services and precision medicine. She has a strong background in NGS and genomics technologies
15/12/2025 - 15/12/2025 Hybrid PSCC Villejuif, France PSCC ESMO Preceptorship on Prostate Cancer 2025: Lugano
ESMO Preceptorship on Prostate Cancer 2025: Lugano organized by ESMO
16/12/2025 - 17/12/2025 In-person ESMO Lugano, Switzerland TBD 1st National Oncology Nursing Conference
1st National Oncology Nursing Conference organized by Oncology Nursing Society of Nigeria (ONSN)
16/12/2025 - 18/12/2025 In-person Oncology Nursing Society of Nigeria (ONSN) Ilishan-Remo, Nigeria TBD Digestive Oncology Autumn Symposium, Edition 2025
Digestive Oncology Autumn Symposium, Edition 2025 organized by Digestive Oncology Group
16/12/2025 - 16/12/2025 In-person Digestive Oncology Group Grimbergen, Belgium TBD Detection of Minimal Residual Disease (MRD): A Highly Sensitive Tool for Monitoring Cancer Patients
We hope to see many of you at this event! Don't miss the next Ecosystem Breakfast on the topic: Detection of Minimal Residual Disease (MRD): A Highly Sensitive Tool for Monitoring Cancer Patients With: Charles Marcaillou, Head of R&D, IntegraGen Charles is a senior scientist and molecular biologist with over 25 years of expertise in genomics and a pioneer in next-generation sequencing technologies. As head of R&D, he has overseen the development, validation, and optimization of the full range of NGS-based applications offered by the company. Séverine Matin-Lannerée, PhD, Head of Quality, IntegraGen Séverine oversees regulatory compliance and quality management for high-throughput sequencing services, with a focus on applications in clinical research and trials, including liquid biopsy. She joined IntegraGen in 2017 after a career in academic and translational research on the molecular bases and mechanisms of cancer. She initially led R&D projects within the oncology biomarker team and acted as a scientific advisor. Céline Capéra, Head of Sales, IntegraGen Céline has led IntegraGen's Commercial team since 2021. Having joined the team in 2010, she has helped IntegraGen become a European leader in genomics services and precision medicine. She has a strong background in NGS and genomics technologies
16/12/2025 - 16/12/2025 Hybrid PSCC Villejuif, France PSCC
ASCO GI 2026
The ASCO Gastrointestinal Cancers Symposium is the leading global forum for the latest high-impact science and solution-focused strategies in the GI cancers field. You don’t want to miss it!
05/01/2026 - 07/01/2026 Hybrid ASCO San Francisco, CA, United States Moscone West AACR Special Conference: Fusion-Positive Cancer: From Discovery to Therapy
Hosted by the American Association for Cancer Research (AACR), the AACR Special Conference on Fusion-Positive Cancers 2026 will bring together leading researchers, clinicians, and translational scientists to discuss the latest advances in fusion oncogene biology, carcinogenesis, and targeted therapeutic strategies. This premier event will explore the genetic and molecular mechanisms driving fusion-driven malignancies, highlighting key topics such as tumor modeling, condensate biology, gene regulatory networks, and novel therapeutic approaches, including small molecule inhibitors, targeted protein degradation, and CRISPR-based technologies. Through plenary sessions, keynote lectures, and poster presentations, attendees will engage in discussions on how cutting-edge research is shaping the future of fusion-positive cancer diagnosis and treatment.
13/01/2026 - 15/01/2026 In-person AACR Philadelphia, PA, United States Hilton Philadelphia at Penn’s Landing Congress of the French Society for Pediatric Hematology and Immunology (SHIP)
In French: "Ce rendez-vous annuel est l’occasion de renforcer nos liens, partager nos connaissances et d’ouvrir ensemble de nouvelles perspectives pour la prise en charge de nos petits patients.Le programme scientifique de cette édition s’annonce particulièrement riche et stimulant. Pendant ces deux jours, nous aborderons trois grandes thématiques : les neutropénies, l’immunologie et les pathologies plaquettaires dans leurs aspects cliniques et génétiques. Le patient étant au cœur de notre pratique, il nous a semblé indispensable de renouveler les sessions d’éducation thérapeutique afin de partager nos expériences."
15/01/2026 - 16/01/2026 In-person Société d’Hématologie Immunologie Pédiatrique (SHIP) Toulouse, France Centre d’enseignement et de congrès de l’hôpital Pierre-Paul Riquet 27th World Congress on Pediatric Oncology and Cancer Care
Pediatric Cancer Innovations: Data, Discovery, and Digital Transformation
19/01/2026 - 20/01/2026 In-person Conference Series Edinburgh, Scotland TBD Overactivation of Oncogenic Signalling as a Potential Cancer Treatment Strategy
This virtual conference will explore a seemingly paradoxical approach to cancer therapy, based on the deliberate hyper-activation of cancer-relevant signalling pathways. Accumulating evidence suggests that this leads to cell death caused by a further activation of cellular stress responses. Target audience: Scientists in academia and industry who are interested in a fundamentally and radically different approach to cancer therapy.
20/01/2026 - 21/01/2026 Virtual EACR Online TBD
4th ParKourS conference: "Des parcours à réinventer"
In French: "Le congrès ParKourS – Agir pour améliorer le parcours de soins en oncologie et hématologie réunira représentants des institutions, professionnels de santé, chercheurs, patients et acteurs engagés dans l’accompagnement des patients pour échanger autour d’initiatives qui améliorent le parcours patient et contribuent à l’évolution des pratiques en onco-hématologie. Cette année, la thématique « Des parcours à réinventer » explorera les enjeux de l’organisation des soins face aux évolutions démographiques, mais aussi les leviers pour améliorer l’accès aux soins de support et diminuer les inégalités d’accès aux soins et aux innovations. Il questionnera aussi le profil des patients de demain, la détection précoce des rechutes, le rôle et le soutien des aidants, l’intégration des professionnels de santé de ville dans le suivi, ou encore l’importance de la décision médicale partagée pour impliquer davantage les patients."
21/01/2026 - 22/01/2026 In-person Unicancer, ITO, l’Association nationale française des IPA (ANFIPA), l’Association française des infirmièr(e)s de cancérologie (AFIC) Lyon, France Centre de Congrès de Lyon 4th ParKourS conference: "Des parcours à réinventer"
In French: "Le congrès ParKourS – Agir pour améliorer le parcours de soins en oncologie et hématologie réunira représentants des institutions, professionnels de santé, chercheurs, patients et acteurs engagés dans l’accompagnement des patients pour échanger autour d’initiatives qui améliorent le parcours patient et contribuent à l’évolution des pratiques en onco-hématologie. Cette année, la thématique « Des parcours à réinventer » explorera les enjeux de l’organisation des soins face aux évolutions démographiques, mais aussi les leviers pour améliorer l’accès aux soins de support et diminuer les inégalités d’accès aux soins et aux innovations. Il questionnera aussi le profil des patients de demain, la détection précoce des rechutes, le rôle et le soutien des aidants, l’intégration des professionnels de santé de ville dans le suivi, ou encore l’importance de la décision médicale partagée pour impliquer davantage les patients."
22/01/2026 - 23/01/2026 In-person Unicancer, ITO, l’Association nationale française des IPA (ANFIPA), l’Association française des infirmièr(e)s de cancérologie (AFIC) Lyon, France Centre de Congrès de Lyon